Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Hypotonic riboflavin
DRUG
2 trials
Sponsors
Cornea and Laser Eye Institute
, Region Skane
Conditions
Corneal Ectasia
Keratoconus
Progressive Keratoconus
Phase 3
Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin
NCT01152541
Cornea and Laser Eye Institute
Corneal Ectasia, Keratoconus
Start: 2010-06-30
End: 2025-12-31
Target: 160
Updated: 2023-02-08
Phase 4
Corneal Crosslinking Treatment Study
Completed
NCT04427956
Region Skane
Progressive Keratoconus
Start: 2017-05-23
End: 2024-11-19
Updated: 2024-11-22
Related Papers
Early findings in a prospective randomised study on three cross-linking treatment protocols: interruption of the iontophoresis treatment protocol
BMJ Open Ophthalmology
2023-09-01
3 citations